Literature DB >> 339866

Listeria cerebritis: relapse of infection in renal transplant patients.

G W Watson, T J Fuller, J Elms, R M Kluge.   

Abstract

In 3 cases of Listeria cerebritis, two of the patients had relapse with cerebritis after antimicrobial therapy for acute Listeria septicemia or meningitis. Each had received ten to 14 days of intravenous penicillin. Relapse occurred with fever and sudden focal cerebral dysfunction. Brain scans showed focal uptake; arteriograms and computerized tomography were normal. Cerebrospinal fluids were nondiagnostic; blood cultures yielded Listeria in two patients. Penicillin treatment for six weeks produced rapid clinical responses that were complete in one and minimal residual in two. Progress brain scans were normal. A relapse rate of 35% is reported in transplant patients with Listeria meningitis and/or bacteremia who are treated for less than three weeks; to our knowledge, cerebritis in such patients has not been reported previously. High-dose penicillin or ampicillin therapy for four to six weeks is recommended for Listeria infections in this select group.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 339866     DOI: 10.1001/archinte.138.1.83

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

1.  In vitro and in vivo studies of imipenem-cilastatin alone and in combination with gentamicin against Listeria monocytogenes.

Authors:  K S Kim
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

2.  Efficacy of ampicillin therapy in experimental listeriosis in mice with impaired T-cell-mediated immune response.

Authors:  I A Bakker-Woudenberg; P de Bos; W B van Leeuwen; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

3.  In vitro activities of trimethoprim and sulfamethoxazole against Listeria monocytogenes.

Authors:  D L Winslow; G A Pankey
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

4.  Cerebritis due to Listeria monocytogenes: CT and MR findings.

Authors:  Y Aladro; P Ponce; V Santullano; A Angel-Moreno; M A Santana
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

5.  Delayed bactericidal activity of beta-lactam antibiotics against Listeria monocytogenes: antagonism of chloramphenicol and rifampin.

Authors:  D L Winslow; J Damme; E Dieckman
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

6.  Bacterial infections of the central nervous system.

Authors:  Katharina M Busl; Thomas P Bleck
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.663

7.  Listeria Cerebritis with Tumor Necrosis Factor Inhibition.

Authors:  Eileen Reilly; Justin Hwang
Journal:  Case Rep Infect Dis       Date:  2020-04-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.